IRIS
CASALE, Maddalena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.289
NA - Nord America 2.659
AS - Asia 2.218
SA - Sud America 401
Continente sconosciuto - Info sul continente non disponibili 225
AF - Africa 37
OC - Oceania 1
Totale 10.830
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.611
US - Stati Uniti d'America 2.599
SG - Singapore 883
CN - Cina 511
IE - Irlanda 506
IT - Italia 489
BR - Brasile 332
HK - Hong Kong 289
VN - Vietnam 230
GB - Regno Unito 167
DE - Germania 166
KR - Corea 99
UA - Ucraina 95
IN - India 55
GR - Grecia 46
FR - Francia 41
JP - Giappone 38
SE - Svezia 34
FI - Finlandia 33
AR - Argentina 31
AT - Austria 26
CA - Canada 25
TR - Turchia 23
MX - Messico 20
NL - Olanda 19
PK - Pakistan 17
BE - Belgio 13
IQ - Iraq 12
ID - Indonesia 11
ZA - Sudafrica 11
BD - Bangladesh 10
CO - Colombia 10
CH - Svizzera 8
DZ - Algeria 7
PY - Paraguay 7
UZ - Uzbekistan 7
VE - Venezuela 7
CL - Cile 6
EC - Ecuador 6
ES - Italia 6
JO - Giordania 5
KE - Kenya 5
CZ - Repubblica Ceca 4
LB - Libano 4
PL - Polonia 4
PT - Portogallo 4
TN - Tunisia 4
EG - Egitto 3
IR - Iran 3
KZ - Kazakistan 3
MA - Marocco 3
RS - Serbia 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GT - Guatemala 2
HN - Honduras 2
LT - Lituania 2
MK - Macedonia 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
PS - Palestinian Territory 1
RO - Romania 1
SC - Seychelles 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.606
Salva come PNG Salva come JPEG
Città #
Moscow 1.301
Dublin 492
Singapore 409
Santa Clara 315
San Jose 306
Hong Kong 286
Chandler 231
Jacksonville 191
Ashburn 160
Seoul 98
Beijing 97
Ann Arbor 88
Ho Chi Minh City 81
Hefei 71
Bremen 70
Princeton 70
Caserta 69
Roxbury 66
Naples 62
Dallas 53
Hanoi 53
Medford 52
New York 47
Council Bluffs 45
Bengaluru 38
The Dalles 37
Woodbridge 35
São Paulo 34
Munich 28
Nanjing 25
Wilmington 25
Des Moines 23
Ercolano 23
Los Angeles 23
Rome 22
Boardman 21
Cambridge 19
Da Nang 18
Grumo Nevano 17
Vienna 17
Napoli 16
Brussels 13
Haiphong 13
Helsinki 13
Nuremberg 12
Atlanta 11
Milan 11
Pescara 10
Belo Horizonte 9
Brooklyn 9
Falkenstein 9
San Mateo 9
Boston 8
Curitiba 8
Johannesburg 8
Montreal 8
Pozzuoli 8
Amsterdam 7
Brasília 7
Houston 7
London 7
Mexico City 7
Nanchang 7
Nocera Inferiore 7
Phoenix 7
Redwood City 7
Rio de Janeiro 7
Tashkent 7
Aversa 6
Chicago 6
Fairfield 6
Hải Dương 6
Istanbul 6
Memphis 6
Mountain View 6
Orem 6
Orlando 6
San Francisco 6
Seattle 6
Shanghai 6
Shenyang 6
Tianjin 6
Turku 6
Asunción 5
Biên Hòa 5
Campinas 5
Chennai 5
Elora 5
Kunming 5
Nairobi 5
Salvador 5
San Sebastiano al Vesuvio 5
Stella Cilento 5
Toronto 5
Amman 4
Auburn Hills 4
Brno 4
Buenos Aires 4
Changchun 4
Fortaleza 4
Totale 5.539
Salva come PNG Salva come JPEG
Nome #
Effects of germline VHL deficiency on growth, metabolism, and mitochondria 225
Cognitive, Brain and Intracranial Artery Involvement in Beta Thalassemia 215
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome 209
Blood transfusions and adverse acute events: a retrospective study from 214 transfusion-dependent pediatric patients comparing transfused blood components by apheresis or by whole blood 198
HNF-1β mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred. 186
Screening for sickle cell disease by point-of-care tests in Italy: pilot study on 1000 at risk children 185
Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. 185
Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload 177
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. 173
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation) 168
Asymptomatic intracranial aneurysms in beta-thalassemia: A three-year follow-up report 167
Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study 161
A Novel 12q13.2-q13.3 Microdeletion Syndrome With Combined Features of Diamond Blackfan Anemia, Pierre Robin Sequence and Klippel Feil Deformity 160
Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience 154
Brain functional impairment in beta-thalassaemia: the cognitive profile in Italian neurologically asymptomatic adult patients in comparison to the reported literature 149
Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned 148
BONE MINERAL DENSITY IMPROVEMENT IN PATIENTS WITH THALASSEMIA MAJOR ON LONG-TERM CHELATION THERAPY WITH DEFERASIROX 146
Congenital Dyserythropoietic Anemia Type II: molecular analysis and expression of the SEC23B Gene. 145
Cb2 receptor stimulation and dexamethasone restore the anti-inflammatory and immune-regulatory properties of mesenchymal stromal cells of children with immune thrombocytopenia 145
Childhood Multiple Endocrine Neoplasia (MEN) Syndromes: Genetics, Clinical Heterogeneity and Modifying Genes 142
No evidence of increased cerebrovascular involvement in adult neurologically-asymptomatic β-Thalassaemia. A multicentre multimodal magnetic resonance study 142
[The Management of Endocrine Complications in Patients with Haemoglobinopathies: Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE).] 141
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multicentre nation-wide cohort 139
Association of immune thrombocytopenia and celiac disease in children: A retrospective case control study 139
Transient erythroblastopenia of childhood after COVID-19 infection: a case report 138
An Educational Study Promoting the Delivery of Transcranial Doppler Ultrasound Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective 137
National systematic approach to the management of asplenia: the set up of the Italian Network on Asplenia 131
Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function 129
Access to emergency department for acute events and identification of sickle cell disease in refugees. 129
Headache in beta-thalassemia: An Italian multicenter clinical, conventional MRI and MR-angiography case-control study 127
Absence of blood donors’ anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients 126
Association between serum ferritin and liver iron concentration with cardiac iron in pediatric thalassemia major patients 125
Characterisation of transfusion-dependent prediabetes using continuous glucose monitoring: The Haemoglycare study 122
Clinical and molecular spectrum of glucose-6-phosphate isomerase deficiency. Report of 12 new cases 119
Long-term efficacy of deferasirox for cardiac siderosis in thalassemia major 117
CB2 and TRPV1 receptors in inflammatory state of macrophages from sickle cell anemia pediatric/young adults 115
Response to measles, mumps and rubella (Mmr) vaccine in transfusion-dependent patients 111
Rubrica a cura di luciano de seta quando il saturimetro mente… 110
Predicting factors for liver iron overload at the first magnetic resonance in children with thalassaemia major 108
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-Thalassemia. 108
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection 107
Deferasirox: la chelazione ottimale nelle anemie trasfusione-dipendenti 105
Management of the risk for severe infections in children with asplenia: Recommendations from the Italian Network of Asplenia 105
Long term efficacy of iron chelation therapy with deferasirox on endocrine function in thalassemia major 104
Iron chelating properties of Eltrombopag: Investigating its role in thalassemia-induced osteoporosis 103
Organizing national responses for rare blood disorders: The Italian experience with sickle cell disease in childhood 102
Splenectomy for hereditary spherocytosis: complete, partial or not at all? 102
Longitudinal Prospective MRI Study in Pediatric Patients With Thalassemia Major 102
Underlying disease is the main risk factor in post-splenectomy complication risk: Data from a national database 101
Life-Threatening Drug-Induced Liver Injury in a Patient with β-Thalassemia Major and Severe Iron Overload on Polypharmacy. 101
Acute chest syndrome in children with sickle cell disease: Data from a national AIEOP cohort identify priority areas of intervention in a hub-and-spoke system 100
Hb Vanvitelli: A new unstable α-globin chain variant causes undiagnosed chronic haemolytic anaemia when co-inherited with deletion − α3.7. 100
Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: Analysis of 78 patients from 21 families 99
Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia 99
No increased cerebrovascular involvement in adult beta-thalassemia by advanced MRI analyses 98
Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology 98
Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey. 95
Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene 95
Second-line therapy in paediatric warm autoimmune haemolytic anaemia. Guidelines from the Associazione Italiana Onco-Ematologia Pediatrica (AIEOP) 94
Prospective MRI study in pediatric thalassemia major (TM) patients in the MIOT network: a tool to strengthen medical decisions 93
HbS/β+ thalassemia: Really a mild disease? A National survey from the AIEOP Sickle Cell Disease Study Group with genotype-phenotype correlation 92
White matter volume changes in adult beta-thalassemia: Negligible and unrelated to anemia and cognitive performances 92
Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major: A Multicenter Study 91
Thyroid Nodule Surveillance in Transfusion-Dependent Thalassemia: A Comparative Ultrasonographic Study 90
Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm 90
Nineteen-month-old girl with persistent fever 89
Long‐term outcomes of avascular necrosis in sickle cell disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study 88
Effect of splenectomy on iron balance in patients with β-thalassemia major: a long-term follow-up 88
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience 88
Myocardial fibrosis by CMR LGE in a large cohort of pediatric thalassemia major patients 87
Reply to "Hepatocellular carcinoma in thalassemia and other hemoglobinopathies" 86
Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE) for the Management of Endocrine Complications in Patients with Haemoglobinopathies 86
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy 86
Red blood cell alloimmunisation in transfusion-dependent thalassaemia: A systematic review 85
Prospective CMR Survey in Children With Thalassemia Major: Insights From a National Network 85
Disease burden and quality of life of in children with sickle cell disease in Italy: time to be considered a priority 85
Incidence of cancer and related deaths in hemoglobinopathies: A follow-up of 4631 patients between 1970 and 2021 84
Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters 84
Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study 82
Subarachnoid haemorrhage and cerebral vasculopathy in a child with sickle cell anaemia 82
Thalassemia-Associated mixed hypogonadism (TAMH): unraveling a unique endocrine pattern and its impact on cardiovascular risk 80
Early splenectomy in sickle cell disease: another piece of the puzzle 80
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry 80
Impairment of Innate Immunity and Depletion of Vaccine‐Induced Memory B and T Cells in the Absence of the Spleen 79
Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose 78
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major 76
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 76
Manual erythroexchange in sickle cell disease: multicenter validation of a protocol predictive of volume to exchange and hemoglobin values 71
Limited access to transcranial Doppler screening and stroke prevention for children with sickle cell disease in Europe: Results of a multinational EuroBloodNet survey 70
Will the changing therapeutic landscape meet the needs of patients with sickle cell disease? 69
Inflammatory and senescence-associated mediators affect the persistence of humoral response to COVID-19 mRNA vaccination in transfusion-dependent beta-thalassemic patients 66
Thalassemias and Sickle Cell Diseases in Pregnancy: SITE Good Practice 56
GROWTH ABNORMALITIES, ENDOCRINE, AND BONE DISEASE 47
FERTILITY AND PREGNANCY. In: Taher AT, Farmakis D, Porter JB, Cappellini MD, Musallam KM, eds. Guidelines for the Management of Transfusion-Dependent β-Thalassaemia (TDT). 5th ed. Nicosia, Cyprus: Thalassaemia International Federation; 2025. 44
The phenotypes of sickle cell disease: strategies to aid the identification of undiagnosed patients in the Italian landscape 42
Oxford Hip and Shoulder Scores as Potential Tools for the Early Detection of Avascular Necrosis in Apparently Unaffected Sites in Sickle Cell Disease: Results from a Prospective Cohort Study 41
Incorporating national disease burden in GBD estimates of haemoglobinopathies in Italy 28
Corrigendum to "Characterisation of transfusion-dependent prediabetes using continuous glucose monitoring: The Haemoglycare study" [Diab. Res. Clin. Pract. 222 (2025) 112076] 23
null 16
Oxford Hip and Shoulder Scores as Potential Tools for the Early Detection of Avascular Necrosis in Apparently Unaffected Sites in Sickle Cell Disease: Results from a Prospective Cohort Study 9
Totale 10.825
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.174
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022451 0 0 7 9 125 31 40 21 23 21 35 139
2022/2023974 103 26 28 60 129 77 0 52 454 10 19 16
2023/2024356 30 14 14 18 132 39 2 10 4 3 28 62
2024/20251.432 10 10 10 44 212 163 244 170 223 110 129 107
2025/20266.144 234 283 332 303 556 3.327 272 269 237 184 104 43
2026/2027377 155 222 0 0 0 0 0 0 0 0 0 0
Totale 10.830